Who am I?

I’m Carolyn and I am Alopecia UK’s Research Manager. I joined the charity in October 2019, just after the Big Weekend. I live in Winchester with my family, cats and chickens.

Before joining the charity, I worked as a scientist. I have a PhD in Immunology and have worked on projects in Type 1 Diabetes and Autoimmune encephalitis. I also work as a funding manager for a local university and I am enjoying using my experience to support Alopecia research.

How did I get involved with Alopecia UK?

I have worked in a few different settings- from hospitals to universities and charities, but I always wanted to be able to work directly with the people affected by the conditions we research. Often working in a research group leaves you feeling divorced from the people who actually have the condition you are studying, so eventually I went to work for a charity helping people who have had a career break get back into science.  This gave me a chance to work more closely with people, but still felt I wanted more involvement with research, so when I was offered the chance to join the team at Alopecia UK, it felt like the perfect opportunity for me.

What are my hopes for Alopecia UK?

Everything! At the Big weekend, I really got the chance to see the impact that such a supportive charity can have on its members. I want to see this continue and for the voices of people with Alopecia be heard. At heart, I am a scientist, so my big aim is to really grow our research funding and make it sustainable, but also to make research more accessible to members and involve members more in the research that we are supporting. The charity has supported some amazing research and I want everyone to be aware of what we are doing.


Influence of HLA-DR and -DQ alleles on autoantibody recognition of distinct epitopes within the juxtamembrane domain of the IA-2 autoantigen in type 1 diabetes. Richardson CC, McLaughlin KA, Morgan D, Feltbower RG, Christie MR. Diabetologia. 2016 Feb; 59(2):334-40. doi: 10.1007/s00125-015-3803-5. Epub 2015 Nov 13

Increased perinatal remodeling of the pancreas in somatostatin-deficient mice: potential role of transforming growth factor-Beta signalling in regulating Beta cell growth in early life. Richardson CC, To K, Foot VL, Hauge-Evans AC, Carmignac D, Christie MR. Horm Metab Res. 2015 Jan;47(1):56-63.

High frequency of autoantibodies in patients with long duration type 1 diabetes. Richardson, CC, Dromey, J. A., McLaughlin, K., Morgan, D., Bodansky, H. J., Feltbower, R. G., Barnett, A. H., Gill, G. V., Bain, S. C. & Christie, M. R. Nov 2013 In : Diabetologia. 56, 11, p. 2538-2540

Failure to detect anti-idiotypic antibodies in the autoimmune response to IA-2 in Type 1 diabetes. Richardson, CC, McLaughlin, K., Brown, T. J., Morgan, D., Feltbower, R., Powell, M., Furmaniak, J., Smith, B. R. & Christie, M. R. Sep 2013 Autoimmunity. 46, 6, p. 375-381

Low levels of glucose transporters and K(ATP) channels in human pancreatic beta cells early in development. Richardson CC, Hussain K, Jones PM, Persaud S, Lobner K, Boehm A, Clark A, Christie MR. Diabetologia. 2007 May; 50(5):1000-1005.